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Abstract:  14 
The endometrium is a dynamic tissue, demonstrating cyclical growth/remodelling in 15 
preparation for implantation. In mice, seminal constituents trigger mechanisms to prepare 16 
the endometrium, a process dubbed ‘seminal priming’ which modifies immune system 17 
components and mediates endometrial remodelling in preparation for pregnancy. An array of 18 
cytokines has been reported to mediate this interaction, although much of the literature 19 
relates to in vitro studies on isolated endometrial epithelial cells. This study measured 20 
changes in immune-related gene expression in endometrial epithelial and stromal cells in 21 
vivo following natural mating. CD1 mice were naturally mated and sacrificed over the first 22 
four days post-coitum (n=3 each day). Endometrial epithelial and stromal compartments 23 
were isolated by laser capture microdissection. Labelled cRNA was generated and 24 
hybridised to genome-wide expression microarrays. Pathway analysis identified several 25 
immune-related pathways active within epithelial and stromal compartments, in particular 26 
relating to cytokine networks, matrix metalloproteinases and prostaglandin synthesis. Cluster 27 
analysis demonstrated that expression of factors involved in immunomodulation/endometrial 28 
remodelling differed between the epithelial and stromal compartments in a temporal fashion. 29 
This study is the first to examine the disparate responses of the endometrial epithelial and 30 
stromal compartments to seminal plasma in vivo in mice, and demonstrates the complexity 31 
of the interactions between these two compartments needed to create a permissive 32 
environment for implantation. 33 
34 
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Introduction 35 
The endometrium is a dynamic tissue which undergoes cyclical growth and remodelling to a 36 
greater or lesser degree in different species in preparation for blastocyst implantation. In the 37 
mouse, seminal constituents are thought to trigger the mechanisms preparing the 38 
endometrium for implantation in a process dubbed ‘seminal priming’ (Figure I), which can 39 
modify immune system components and influence subsequent events in pregnancy 40 
(Robertson, et al. 2013). The endometrium responds rapidly to seminal fluid exposure by 41 
triggering an inflammatory cascade which is soon followed by an influx of leukocytes 42 
(Sharkey, et al. 2012). Seminal plasma proteins interact with oestrogen (E2)-primed uterine 43 
epithelial cells, resulting in the synthesis of a large array of cytokines and other 44 
immunoregulatory factors, such as granulocyte macrophage colony stimulating factor 45 
(CSF2), interleukin (IL)6, IL8, monocyte chemoattractant protein (CCL2), matrix 46 
metalloproteinases (MMPs) and prostaglandins (PGs) (Robertson, et al. 1996a, Sanford, et 47 
al. 1992). Within hours of this rise in cytokine production, inflammatory cells invade the 48 
cervix as the primary site of semen deposition in humans, pigs, rabbits and mice, although in 49 
rodents this inflammatory response can be seen throughout the endometrium (Claus 1990, 50 
Lovell and Getty 1968, McMaster, et al. 1992, Pandya and Cohen 1985, Robertson 2005, 51 
Rozeboom, et al. 1998, Taylor 1982). Myeloid lineage cells such as 52 
monocytes/macrophages, dendritic cells and granulocytes of circulatory origin extravasate to 53 
accumulate in uterine stromal tissue, with macrophages, neutrophils and other granulocytes 54 
in particular further traversing the epithelium to accumulate in the uterine cavity (Bischof, et 55 
al. 1994, De, et al. 1991, McMaster, et al. 1992). This initial neutrophil response resolves 56 
prior to implantation, with a purported concurrent drop in cytokine profiles and rise in 57 
progesterone (P4) (Robertson, et al. 1996a). Endometrial leukocytes, however, persist for 58 
several days (O'Leary, et al. 2004).  59 
 60 
Cytokines such as CSF2 (Robertson, et al. 1996b, Robertson and Seamark 1990), 61 
leukaemia inhibitory factor (LIF), CCL2 (Boomsma, et al. 2009, Meter, et al. 2005, Wood, et 62 
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al. 1997, Wood, et al. 1999), regulated upon activation normal T cell expressed and secreted 63 
(CCL5) (Altman, et al. 1999, Arima, et al. 2000, Wood, et al. 1997) and TGFB have been 64 
shown to be expressed in endometrial cell compartments post-coitum, although much of 65 
these data relate to in vitro models. However, most of the peri-implantation tissue 66 
remodelling (both prior to and during decidualisation) appears to be mediated by MMPs 67 
(Aplin 1997, Tang, et al. 2005). Several MMPs have been implicated, with macrophages 68 
being the main source of these proteases, which they produce in response to the prevailing 69 
cytokine and prostaglandin milieu (Goetzl, et al. 1996). However, MMP function is 70 
reasonably species-specific: in women, these enzymes are the main mediators of 71 
endometrial shedding whereas this process is largely absent in rodents, where endometrial 72 
remodelling merely involves functional regression (Marbaix, et al. 1996, Tang, et al. 2005).  73 
 74 
Alongside endometrial remodelling, a concurrent modification of the maternal immune 75 
system occurs in order to promote maternal immunotolerance of the paternal antigens 76 
displayed by the implanting blastocyst. Following initial semen deposition in the female 77 
reproductive tract, paternal antigens are phagocytosed, processed and presented to 78 
maternal CD4+ and CD8+ T cells by antigen presenting cells in the para-aortic lymph nodes 79 
(Johansson, et al. 2004, Moldenhauer, et al. 2009). This induces a functional 80 
anergy/hyporesponsiveness in these cells which promotes conceptus allograft tolerance 81 
(Tafuri, et al. 1995), in line with a concurrent expansion of the CD4+CD25+Foxp3+ regulatory 82 
T cell (Treg) pool (Aluvihare, et al. 2004, Shima, et al. 2010). The strength of this maternal 83 
response depends on seminal plasma composition, particularly paternal antigen content and 84 
TGFB concentrations (Robertson, et al. 2009). Seminal plasma TGFB in humans and swine 85 
is largely accounted for by the TGFB1 isoform (although TGFB2 and 3 are also present) 86 
which is secreted in an inactive form requiring activation in the acidic environment of the 87 
vagina (Politch, et al. 2007). The activation of TGFB1 induces naïve CD4+CD25- T cells to 88 
differentiate into Foxp3+ suppressor/anergic T cells (Chen, et al. 2003). The prostaglandin 89 
component of seminal plasma may also synergise with TGFB in this regard since PGE2 90 
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enhances this inhibitory effect and has been shown to induce a regulatory phenotype in 91 
human CD4+CD25- T cells in vitro (Baratelli, et al. 2005). PG synthesis is also induced by 92 
seminal plasma in the porcine uterus, with concurrent angiogenesis extending throughout 93 
the preimplantation period (Kaczmarek, et al. 2010, Kaczmarek, et al. 2013). 94 
 95 
Although individual immune mediators of the endometrial response to seminal plasma have 96 
been identified, few studies have focussed on trying to paint a comprehensive picture of the 97 
large numbers of mediators involved, particularly in terms of characterising the global 98 
immunomodulatory responses involved at the level of the transcriptome. Various studies 99 
have focussed on profiling gene expression over the course of the implantation window 100 
(particularly in women following ovarian stimulation) in order to identify those genes most 101 
likely to be involved in the establishment of endometrial receptivity prior to embryo transfer 102 
and in relation to the implantation problems allied to endometriosis (Burney, et al. 2007, 103 
Giudice 2004, Kao, et al. 2003, Kao, et al. 2002, Riesewijk, et al. 2003). To date, however, 104 
only one has explored global gene expression in the cervix following stimulation with seminal 105 
plasma: Sharkey and co-workers (2012) performed expression microarray analysis on 106 
biopsies of pre- and post-coital human cervix and reported that seminal fluid activated 107 
pathways including the inflammatory response, immune response, immune cell trafficking, 108 
cell movement, and antigen presentation. Within these various pathways, CSF2, IL6 and IL8 109 
mRNA were prominently upregulated post-coitum, as were COX-2 and various MMPs, 110 
suggesting active leukocyte recruitment and ECM remodelling (Sharkey, et al. 2012). 111 
Unfortunately, these observations were based only on a single time point in this putatively 112 
dynamic process. The aim of the present study was therefore to characterise the 113 
endometrial inflammatory response to seminal plasma in vivo in detail throughout the pre-114 
implantation period by using a genome-wide screening approach using a murine model. 115 
Furthermore, the individual response of the epithelial and stromal cellular compartments to 116 
seminal plasma was examined to identify differences in gene expression. 117 
118 
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Materials and Methods 119 
Mouse husbandry and mating protocol 120 
Ethical approval was not required for this study as all work was conducted in compliance 121 
with the ethical and legislative framework set out in the Animals (Scientific Procedures) Act, 122 
1986 (UK). Individually housed male (aged 10-12 weeks), and group housed (10 per cage) 123 
nulliparous female (aged 6 weeks) CD1 mice were used for these experiments. Animals had 124 
ad libitum access to water and Standard Expanded Beekay diet (B&K, Grimston, 125 
Aldborough, UK). The lighting cycle was 14h:10h light:dark, (05:30 on; 19:30 off) and 126 
humidity and temperature were maintained at 55-65% and 21.5±1°C, respectively. Whitten 127 
effect synchronised females had their oestrus confirmed by vaginal cytology prior to being 128 
naturally mated to CD1 stud males (1 female:1 male). Five successful copulations were 129 
recorded prior to leaving pairs together overnight in order to confirm successful intercourse. 130 
Females were then group housed according to time of mating, before being sacrificed under 131 
Schedule 1 of the Animals (Scientific Procedures) Act, 1986 at 24, 48, 72 and 96 hours post 132 
first coitus ±1 hour (n=3 per group). Controls were provided by naturally cycling oestrus and 133 
dioestrus females (again assessed on the basis of vaginal cytology, n=3 per group). 134 
 135 
Uterine tissue processing and staining 136 
Within five minutes of culling, the ovaries, uterine horns and vagina were mounted in optimal 137 
cutting compound (OCT), frozen in isopentane slush in a liquid nitrogen bath before storage 138 
at -80oC. Specimens were later sectioned (12µm) at -16oC on a Leica CM3050S Cryostat 139 
(Leica Biosystems, UK). Sections were mounted onto Arcturus polyethylene naphthalate 140 
(PEN) membrane glass slides (Applied Biosystems, CA, USA) and stained with buffered 141 
ethanolic cresyl violet staining solution, as previously described, with minor modifications 142 
(Cummings, et al. 2011). Briefly, sections were rehydrated in a series of ethanol washes (95, 143 
75 and 50%) prior to staining with cresyl violet in 75% ethanol buffered with 20 mM Tris-HCl 144 
pH 8.0 for 40 seconds. Sections were then dehydrated in a series of ethanol washes (50, 75, 145 
95 and 100%). All solutions were prepared using RNAse free water and molecular grade 146 
Page 6 of 36
absolute ethanol. Slides were stored at -80oC under dessicant prior to laser capture 147 
microdissection (LCM). 148 
 149 
Laser capture microdissection 150 
LCM of selected groups of cells was performed on a Zeiss Palm® Microbeam UV laser 151 
capture microscope, equipped with PALM@Robo software version 3.2 (Carl Zeiss, Herts, 152 
UK). Samples were captured with cut energy set to 51-60% and laser speed of 20µm/s. 153 
Excised areas were captured into adhesive cap tubes (Carl Zeiss, Herts, UK), with the 154 
average area excised per sample being 3.23x106 µm2. Both lumenal epithelial and stromal 155 
compartments were independently microdissected from the same tissue specimens in order 156 
to avoid the risk of RNA cross-contamination (Supplementary Figure I).  157 
 158 
RNA preparation and microarray analysis 159 
RNA extraction was performed using Qiagen RNeasy plus micro extraction kits (Qiagen, 160 
UK). The extraction protocol was based on the manufacturer’s instructions with minor 161 
modifications; one extra RPE and 80% ethanol wash step was incorporated in order to 162 
reduce impurity carryover and improve RNA quality. Samples were eluted from the spin 163 
column by addition of 14µl RNAse-free water, with 0.5µl RNASecure (Ambion) immediately 164 
added to the eluate, which was then heated to 60°C for 10 minutes to inactivate RNase. 165 
Samples were concentrated using a Savant SpeedVac® concentrator (Eppendorf, Hamburg, 166 
Germany) for 30 minutes or until dry, then resuspended in 4µl RNAse-free water and stored 167 
at -80oC until use. RNA quality and quantity was assessed using Agilent RNA 6000 Nano kit 168 
(Agilent, UK) on a 2100 Bioanalyser (Agilent, UK) equipped with 2100 Expert software using 169 
the RNA Eukaryote Total RNA Nano function, only samples with a RIN value of 7 and above 170 
were considered suitable for fluorescent cRNA generation. 171 
 172 
Fluorescent cRNA was prepared using Agilent One Colour Low Input Quick AMP labelling kit 173 
with 10ng input RNA. Purification of RNA was performed using the RNeasy Mini kit (Qiagen 174 
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UK) following the manufacturer’s instructions. Replicates were hybridised in different batches 175 
to avoid experimental bias. Fluorescent cRNA quality was assessed using a NanoDrop 1000 176 
(Thermo-Scientific UK). Cyanine (Cy3) concentration (pmol/µl), RNA 260/280 ratio and 177 
cRNA concentration (ng/µl) were also recorded, and yield and specific activity were 178 
calculated for each sample. Samples were hybridised to Agilent SurePrint G3 Mouse GE 179 
8x60k microarrays as per manufacturer’s instructions. Hybridisation was performed in a 180 
hybridisation oven (Agilent, UK) for 17 hours at 65oC and a rotation speed of 20rpm. 181 
Subsequent washes were completed within 1 hour. Slides were scanned immediately to 182 
reduce potential variations in signal intensities due to environmental contaminants.  183 
 184 
Scanning and feature extraction 185 
Microarrays were scanned using an Agilent ‘C’ scanner (Agilent, UK), with a scan resolution 186 
of 3µm. Feature extraction was performed using Feature Extraction version 11.0.1.1 (Agilent 187 
Technologies, UK). Sample quality was assessed utilising inbuilt quality control metrics. 188 
Eleven of these were applied to the microarray, covering aspects such as alignment, signal 189 
intensity and reproducibility, providing a range within which a microarray is considered 190 
‘good’. Microarrays falling outside of the manufacturer’s ‘good’ criteria were evaluated for 191 
exclusion from the final analysis. 192 
 193 
Data analysis 194 
Data were visualised and analysed using GeneSpring version 12.5 (Agilent Technologies, 195 
UK). Data were normalised to the 75th percentile signal intensity of all probes on the array 196 
as recommended by the manufacturer. Samples were examined by the inbuilt principal 197 
components analysis (PCA) to identify major outliers. Sample size and desired fold 198 
difference were calculated using the Microarray Sample Size Computation tool available at 199 
http://bioinformatics.mdanderson.org/microarraysamplesize/. The calculation was based on 200 
55821 entities, with an acceptable false positive rate of 5%, power (percentage of 201 
differentially expressed entities likely to be detected by the experiment) of 0.8, and a 202 
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standard deviation of 0.7. Due to the sample size, a 5-fold change cut-off was applied to the 203 
data. Pathway analysis was performed using the condition averages in order to identify 204 
immune pathways active in the murine endometrium. P values were corrected for multiple 205 
comparisons using the Benjamini and Hochberg false discovery rate (FDR). The results from 206 
the pathway analysis were used in subsequent cluster analyses in IBM SPSS (Version 19). 207 
The analysis was performed for epithelium and stroma individually, based on a two-step 208 
cluster analysis using Ward linkage. At each iteration, the ∆ coefficient was calculated, with 209 
the largest ∆ coefficient defining the number of clusters. Identified mRNA species in each 210 
cluster were visualised in GraphPad Prism (Version 6). 211 
212 
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Results 213 
Pathway analysis 214 
Pathway analysis revealed 217 curated pathways active within the murine uterine tract. Of 215 
these pathways, 46 were significant at P<0.05, with significance defined by the inbuilt 216 
GeneSpring algorithm which created a composite score of the number of mRNA species 217 
matched and the extent of the response of those species (Table 1). Those relating to 218 
immune networks were selected in both endometrial epithelial and stromal cell 219 
compartments active within the murine endometrium: Prostaglandin synthesis and regulation 220 
(P<0.001), Cytokines and inflammatory response (P<0.001), MMPs (P=0.01), Inflammatory 221 
response pathway (P<0.05), and the TGFB signalling pathway (P<0.05).  222 
 223 
Cluster analysis – epithelial compartment 224 
Genes encoding cytokine proteins and MMPs highlighted in the pathway analysis were 225 
selected for subsequent cluster analysis. These elements fell into 8 clusters (Figure II). 226 
Cluster 1 was defined by peaks in expression on days 1 and 3 post mating with reduced 227 
expression on day 2 (Cxcl3, Il10, Il12a, Mmp9, Mmp20, Mmp25, Tnf). Cluster 2 exhibited a 228 
similar pattern of peaks on days 1 and 3, with a less dramatic reduction in expression on day 229 
2 (Bmp4, Egf, Il7, Il13, Mmp1a, Mmp3, Mmp16, Mmp28). Cluster 3 generally showed a peak 230 
in expression at oestrus and day 2 post mating with a reduction in expression on day 1 231 
(Ccl5, Csf3, Il1b, Il15, Inhb1, Mmp11, Mmp14, Mmp23, Thbs). Cluster 4 demonstrated a 232 
slight peak at dioestrus and day 1 post mating (Ifng, Mcp1, Mmp2, Mmp19, Tgfb1, Tgfb2, 233 
Tgfb3). Cluster 5 showed a dip in expression at oestrus, while remaining relatively constant 234 
at other time points (Csf2, Cxcl2, Il2, Il4, Il5, Il12b, Itbp1, Mmp10, Mmp12, Mmp13, Mmp21, 235 
Mmp24). Cluster 6 exhibited minor peaks on days 2 and 4 post mating, although many 236 
elements showed large variation (Cxcl1, Il1a, Lif, Mmp8, Mmp27). Cluster 7 was 237 
characterised by peaks at dioestrus, day 1 and day 4 post mating, with a dramatic reduction 238 
in expression at day 2 and 3 (Csf1t1, Csf1t3, Mmp7). Finally, cluster 8 elements exhibited 239 
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huge variations in expression at each time point, and therefore could not be ascribed to any 240 
particular pattern. 241 
 242 
Cluster analysis – stromal compartment 243 
mRNA entities fell into 7 clusters (Figure III). Cluster 1 comprised three mRNA species 244 
(Csf1t1, Csf3, Mmp23) which exhibited a peak at oestrus. Cluster 2 was characterised by a 245 
slight increase in expression on day 1 post mating, with a subsequent decrease on days 2, 3 246 
and 4 (Bmp4, Csf1t3, Csf2, Cxcl2, Cxcl3, Egf, Ifnb1, Il1a, Il2, Il4, Il5, Il6, Il7, Il10, Il11, Il12a, 247 
Il12b, Il13, Mmp1a, Mmp3, Mmp8, Mmp10, Mmp13, Mmp12, Mmp16, Mmp20, Mmp21, 248 
Mmp24, Mmp25, Mmp28, Tnf). Cluster 3 comprised only Mmp7, which showed highest 249 
expression at oestrus with lowest expression on day 3 post mating. Cluster 4 increased in 250 
expression post mating and remained high on days 2, 3 and 4 (Ifng, Il15, Mmp2, Mmp19, 251 
Tgfb1, Tgfb2, Tgfb3). Cluster 5 peaked on days 1 and 2 post mating with a subsequent 252 
decrease on days 3 and 4 (Ccl5, Inhb1, Il1b, Mcp1, Mmp9, Thbs1). Cluster 6 peaked on day 253 
1 with a subsequent fall to baseline levels of expression (Mmp11, Mmp14). Cluster 7 was 254 
characterised by peaks in expression at dioestrus and day 3 post mating (Cxcl1, Itbp1, Lif, 255 
Mmp27). 256 
 257 
Differences in endometrial epithelial and stromal expression 258 
Many mRNA species displayed differences in expression between endometrial epithelial and 259 
stromal cells despite exhibiting similar pathway involvement. The majority showed greater 260 
relative expression profiles in stromal cells as compared to epithelial cells, with the exception 261 
of Mmp7 and elements of the prostaglandin pathway which were consistently more highly 262 
expressed in epithelial cells.  263 
 264 
Colony stimulating factors (CSFs) varied in expression in each cell type with notable 265 
differences in both transcript variants of Csf1 (Figure IV). This mRNA peaked on days 1 and 266 
4 post mating in the epithelium, while stromal expression remained relatively constant. Csf2 267 
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showed a minor peak in expression on day 1 post mating in both epithelium and stroma, with 268 
epithelial expression peaking on day 4 while stromal expression slowly declined. Of the 269 
CSFs, Csf3 showed the greatest difference in expression between epithelium and stroma, 270 
with a dramatic drop in epithelial expression on day 1 followed by a peak on day 2 post 271 
mating. 272 
 273 
Transforming growth factors (TGFs) were consistently more highly expressed in stroma than 274 
in epithelium (Figure V). Tgfb1 exhibited a divergence between stromal and epithelial 275 
expression on day 1 post mating, with stromal expression increasing while epithelial 276 
expression decreased. Tgfb2 showed a similar divergence on day 2 post mating. Interferons 277 
(Ifnb and Ifng) were both detected in murine endometrium, with a higher relative expression 278 
noted in stroma (Figure VI). There was one exception to this pattern: Ifnb epithelial 279 
expression peaked above stromal expression on day 2 post-coitum. Differences were noted 280 
in other inflammatory cytokines too: Tnf, Lif and Ccl5 were all expressed in endometrial 281 
stroma at relatively higher levels than in epithelium, with the exception of Tnf and Lif on day 282 
4 (Figure VII). Ccl5 expression patterns were similar in both compartments post-coitum. 283 
 284 
Elements of the prostaglandin pathway were also implicated: prostaglandin synthases were 285 
detected in both endometrial epithelium and stroma (Figure VIII). Ptgs1 (Cox1) 286 
demonstrated a dramatic increase in epithelial expression which was relatively higher than 287 
stromal expression on day 2 post mating; this was sustained until a day 4 drop. Ptgs2 (Cox2) 288 
peaked in the epithelium on day 2 post-coitum. The prostaglandin E receptors Ptger1, 289 
Ptger2, Ptger3 and Ptger4 exhibited differences in expression between endometrial epithelial 290 
and stromal cells. Both Ptger1 and Ptger3 were more highly expressed in stroma than in 291 
epithelium. Ptger1 showed an increase in stromal expression with a concurrent decrease in 292 
epithelial expression on day 2 post mating. Ptger2 and Ptger4 were consistently more highly 293 
expressed in epithelium than in stroma. Ptger2 peaked on days 1 and 4 post mating, while 294 
Ptger4 peaked on day 3 (Figure VII).  295 
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Discussion 296 
This study characterised the murine endometrial epithelial and stromal responses to seminal 297 
plasma in the development of maternal immunotolerance to the foetal allograft. Various 298 
mediators of this response have been identified. Chief amongst these, CSF2 is secreted into 299 
the uterine lumen within hours of coitus (Robertson, et al. 1996b, Robertson and Seamark 300 
1990). This ties in well with the present findings, where Csf2 expression was noted to rise 301 
markedly between oestrus and day 1 in both epithelial and stromal compartments. Relative 302 
stromal expression exceeded that of the epithelium except on day 4, suggesting that stroma 303 
may be the principal source of CSF2. This challenges the conventional epithelium-centric 304 
view borne from studies based on trypsinised cell cultures or antibody-based panning 305 
techniques which may alter epithelial cell phenotype and response (Robertson, et al. 1992, 306 
1996b, Robertson and Seamark 1990). Moreover, the stromal role is often overlooked in the 307 
design of such investigations. Csf2 mRNA extracted from entire murine uteri post coitum has 308 
been shown to be upregulated across days 1-2 (Robertson, et al. 1996a), in contrast to the 309 
day 2 decline reported here. This may reflect differences in mouse strain or use of the entire 310 
organ mRNA pool rather than the more selective approach used herein. CSF2 was raised on 311 
day 1 post mating in both epithelium and stroma, pointing to its likely involvement in the 312 
endometrial response to seminal plasma. Epithelial Csf2 expression was highest on day 4, 313 
suggesting its involvement in endometrial receptivity to the implanting blastocyst. Indeed, 314 
CSF2 recruits leukocytes to the endometrium to facilitate implantation, with dendritic cells, 315 
regulatory T cells and natural killer cells coordinating trophoblast invasion (Bulmer, et al. 316 
1991, Chaouat 2013, Erlebacher 2013, Fu, et al. 2013, Gonzalez, et al. 2012, Hatta, et al. 317 
2012, Hemberger 2013, Male, et al. 2012). Its importance in placentation is highlighted by a 318 
study of null mice which showed that absence of CSF2 was associated with late pregnancy 319 
loss and delayed foetal growth (Seymour, et al. 1997). CSF1 is a weak chemotactic agent, 320 
recruiting macrophages to the epithelium (Wood, et al. 1997), such that its protein levels 321 
correlate with macrophage numbers (Pollard, et al. 1987). In the present study, epithelial 322 
Csf1 expression peaked on days 1 and 4, suggesting two waves of macrophage recruitment. 323 
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Conceivably, the day 1 wave could be accounted for by the role of macrophages as antigen-324 
presenting cells in the induction of maternal immunotolerance alongside their phagocytic 325 
clearance of seminal components within the uterine lumen (Olive, et al. 1987) while on day 326 
4, they may participate in tissue remodelling and increasing epithelial cell adhesiveness in 327 
preparation for implantation (Lee, et al. 2011).  328 
 329 
Epithelial cluster 1 transcripts (Cxcl3, Il10, Il12a, Mmp9, Mmp20, Mmp25, Tnf) peaked on 330 
days 1 and 4 post mating. TNFA is key to the acute inflammatory response (Warren, et al. 331 
1988), accounting for its early expression. CXCL3 controls monocyte adhesion and 332 
migration (Smith, et al. 2005), thus likely mediating macrophage recruitment. Although 333 
CXCL3 is induced by IL13 (Ooi, et al. 2012), their transcripts did not cluster, potentially due 334 
to functional redundancy (see later). MMPs also featured prominently in the initial epithelial 335 
response to seminal plasma, suggesting some degree of early remodelling and/or 336 
neoangiogenic signalling to stroma in preparation for implantation (Rundhaug 2005). 337 
 338 
Expression of epithelial clusters 3 (Ccl5, Csf3, Il1b, Il15, Inhb1, Mmp11, Mmp14, Mmp23, 339 
Thbs1) and 6 (Cxcl1, Il1a, Lif, Mmp8, Mmp27) was downregulated on day 1 post mating. 340 
This is surprising since Ccl5, Csf3, Cxcl1 and Il15 are leukocyte chemotactic/differentiation 341 
agents whose levels might be expected to parallel leukocyte activity post coitum (Ashkar, et 342 
al. 2003, Bleul, et al. 1996, Kryczek, et al. 2005, Schall, et al. 1990, Wood, et al. 1997). 343 
Instead, Ccl5 and Il15 expression rose in stroma, suggesting that this compartment may be 344 
their principal source. This may also reflect a degree of functional redundancy, a 345 
phenomenon partly due to cytokine receptors sharing a common subunit specific to a family 346 
of cytokines. For example, IL2 deficiency can be compensated by other cytokines in its 347 
family (IL4, IL7, IL9, IL15, IL21) which signal through its receptor by binding to the common 348 
γ-chain (Lin, et al. 1995, Ozaki and Leonard 2002). This family of interleukins falls into 349 
clusters 3 and 5 whose expression either fails to increase above baseline or is 350 
downregulated post mating, with the exception of Il7 (cluster 2) which peaked on days 1-3. It 351 
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is tempting to speculate that Il7 performs an overarching function on behalf of its family, 352 
rendering the others functionally redundant. Alternatively, other mediators may operate as 353 
selective suppressors of Il4, Il9, Il15 and Il21 expression although this cannot be determined 354 
from our data. The apparent day 1 downregulation of Il1a and Il1b may be due to the fact 355 
that the inflammatory response may peak and fall prior to day 1 sampling. This is 356 
conceivable since cytokine expression increases within hours (e.g. <3 hours for Il1b in 357 
human endometrial epithelial cells in vitro) (Gutsche, et al. 2003). It is however more 358 
probable that the inflammatory response itself is modified to induce maternal tolerance to 359 
paternal antigens without necessarily involving the stereotypical acute phase cytokine 360 
cascade. 361 
 362 
Prostaglandin-endoperoxide synthases (PTGSs; cyclooxygenases) shape the implantation-363 
related prostaglandin response and influence immune function, angiogenesis and tissue 364 
remodelling (Salleh 2014). We found that post coitum Ptgs1 and Ptgs2 expression localised 365 
to the epithelium, a profile reflected by their protein localisation in both post-mating rats and 366 
cycling human uteri (Yang, et al. 2002). Prostaglandin receptor Ptger1 and Ptger3 367 
expression rose in stroma in parallel to epithelial Ptgs2, suggesting paracrine interactions 368 
between the two compartments. Cluster 2 (Bmp4, Egf, Il7, Il13, Mmp1a, Mmp3, Mmp16, 369 
Mmp28) epithelial expression rose post mating and was sustained until day 4. EGF and IL7 370 
are functionally similar in inducing immune effector cell proliferation and differentiation (Niu 371 
and Qin 2013) while IL13 modulates human monocyte/B cell function and downregulates/ 372 
induces MMPs based on the physiological setting (Bailey, et al. 2012, Firszt, et al. 2013, 373 
Wadsworth, et al. 2010). Their sustained mRNA expression supports their role in inducing 374 
immunotolerance and stromal remodelling. 375 
 376 
As regards the stromal response, cluster 5 (Ccl5, Il1b, Inhb1, Mcp1, Mmp9, Thbs1) was of 377 
most interest; expression peaked on days 1-2 post mating and fell on days 3-4. In contrast to 378 
the epithelial response, the increase in Il1b expression suggests that its stromal function 379 
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may relate to its role in governing cell proliferation/differentiation, inducing PTGS2 380 
expression and regulating MMPs (Rossi, et al. 2005), in agreement with the rise in day 2 381 
stromal Ptgs2 expression. IL1B also likely influences the steroid hormone microenvironment 382 
through its suppression of steroid sulphatase activity (Matsuoka, et al. 2002), thereby 383 
reducing stromal oestrogenic effects so as to create an environment favourable for nidation. 384 
The remaining cluster 5 members mediate leukocyte recruitment and extracellular 385 
remodelling in preparation for implantation, as discussed earlier. 386 
 387 
Cluster 4 (Ifng, Il15, Mmp2, Mmp19, Tgfb1, Tgfb2, Tgfb3) stromal gene expression levels 388 
rose on day 1 and remained high thereafter, in contrast to the epithelium. While these agents 389 
regulate epithelial proliferation/remodelling in the menstrual cycle (Godkin and Dore 1998, 390 
Gold, et al. 1994), this apparent discrepancy may reflect a paracrine stroma:epithelial 391 
relationship, such that bidirectional communication is essential to coordinate the preparatory 392 
changes for implantation. TGFB1 can inhibit proliferation and induce PTGS2/prolactin 393 
expression in human endometrial stromal cells in vitro (Chang, et al. 2008), pointing to a role 394 
in tissue remodelling in preparation for decidualisation, as supported by the present data. 395 
MMP2 and 9 cleave latent TGFB into its active form (Yu and Stamenkovic 2000), accounting 396 
for our observation that Mmp2 clusters with all TGFB isoforms in both epithelium and 397 
stroma. As such, MMP:TGFB signalling pathway interactions may participate in creating the 398 
immunopermissive environment of implantation. In contrast with our findings, a murine study 399 
showed TGFB2 expression to be confined to the epithelium during the preimplantation 400 
period (Das, et al. 1992), which may reflect post-transcriptional processes. Ifng and Tgfb 401 
isoform transcript clustering in stroma was expected given that these cytokines display 402 
antagonistic relationships (Eickelberg, et al. 2001, Higashi, et al. 2003, Yu, et al. 2006). In 403 
murine and human endometrial epithelium, IFNG has a strong inhibitory effect on TGFB via 404 
TGFB type II receptor (Tgfbr2) downregulation (Yu, et al. 2006). Ifng is unlikely to perform a 405 
similar role in stroma since Tgfbr2 was upregulated on day 1 post mating (data not shown). 406 
Instead, the parallel reduction in Tgfbr2 expression in the epithelium points to paracrine 407 
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stromal:epithelial interactions. A likely endometrial role for both these agents revolves 408 
around regulating T cell function: IFNG induces T cell apoptosis/inhibits their proliferation, 409 
while TGFB promotes naïve T cell differentiation into Tregs (Chen 2011). IFNG also has 410 
anti-proliferative effects on human endometrial epithelial cells in vitro (Tabibzadeh, et al. 411 
1988) and an inhibitory effect on stromal VEGF production (Kawano, et al. 2000), which is at 412 
odds with post coital endometrial events occurring in vivo. 413 
 414 
To our knowledge, this is the first study to characterise comprehensively the post coitum 415 
physiological changes in endometrial epithelial and stromal gene expression. Immune 416 
pathways were most affected and exhibited dynamic, quantitatively and chronologically 417 
distinct compartment-specific changes. Since the expression and bioactivity of many of the 418 
mediators involved are subject to both post-transcriptional and post-translational regulation, 419 
future studies should focus analyses at the protein level to draw more functional 420 
interpretations. Moreover, the cluster analysis used herein (and in other studies) is based on 421 
pre-defined pathways intrinsic to microarray analytical software which may be overly 422 
prescriptive and prevent the identification of novel, broader network interactions (e.g. 423 
cytokine/eicosanoid/hormone interactions in inflammatory networks). This calls for new 424 
analytical and modelling strategies which account for these phenomena. 425 
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Legends 
 
Figure I: Schematic diagram representing the complex interplay between murine 
endometrial epithelial and stromal cells following exposure to semen/seminal plasma. 
Cytokines, matrix metalloproteinases (MMPs) and prostaglandins (PGs), mediate the 
development of immunotolerance and tissue remodelling in the peri-implantation period to 
prepare for implantation and subsequent pregnancy. 
 
Figure II: Cluster analysis of mRNA encoding cytokines and MMPs in murine endometrial 
epithelial cells. Clusters were identified by a two-step cluster analysis using Ward linkage. At 
each iteration, the ∆ coefficient was calculated, with the largest ∆ coefficient defining the 
number of clusters. Cluster membership: Cluster 1 - Cxcl3, Il10, Il12a, Mmp9, Mmp20, 
Mmp25, Tnf; Cluster 2 - Bmp4, Egf, Il7, Il13, Mmp1a, Mmp3, Mmp16, Mmp28; Cluster 3 - 
Ccl5, Csf3, Il1b, Il15, Inhb1, Mmp11, Mmp14, Mmp23, Thbs; Cluster 4 - Ifng, Mcp1, Mmp2, 
Mmp19, Tgfb1, Tgfb2, Tgfb3; Cluster 5 - Csf2, Cxcl2, Il2, Il4, Il5, Il12b, Itbp1, Mmp10, 
Mmp12, Mmp13, Mmp21, Mmp24; Cluster 6 - Cxcl1, Il1a, Lif, Mmp8, Mmp27; Cluster 7 - 
Csf1t1, Csf1t3, Mmp7; Cluster 8 - Ifnb, Il6, Il11. 
 
Figure III: Cluster analysis of mRNA encoding cytokines and MMPs in murine endometrial 
stromal cells. Clusters were identified by a two-step cluster analysis using Ward linkage. At 
each iteration, the ∆ coefficient was calculated, with the largest ∆ coefficient defining the 
number of clusters. Cluster membership: Cluster 1 - Csf1t1, Csf3, Mmp23; Cluster 2 - Bmp4, 
Csf1t3, Csf2, Cxcl2, Cxcl3, Egf, Ifnb1, Il1a, Il2, Il4, Il5, Il6, Il7, Il10, Il11, Il12a, Il12b, Il13, 
Mmp1a, Mmp3, Mmp8, Mmp10, Mmp13, Mmp12, Mmp16, Mmp20, Mmp21, Mmp24, 
Mmp25, Mmp28, Tnf; Cluster 3 - Mmp7; Cluster 4 - Ifng, Il15, Mmp2, Mmp19, Tgfb1, Tgfb2, 
Tgfb3; Cluster 5 - Ccl5, Inhb1, Il1b, Mcp1, Mmp9, Thbs1; Cluster 6 - Mmp11, Mmp14; 
Cluster 7 - Cxcl1, Itbp1, Lif, Mmp27. 
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Figure IV: Relative CSF mRNA expression in murine endometrial epithelial and stromal cells 
post coitum. Csf1 (both transcript variants) varied little in the epithelium, while peaking on 
day 1 and 4 in the stroma. Csf2 exhibited higher stromal expression at all time points except 
day 4. Csf3 exhibited the most variation across cell type and time point. 
 
Figure V: Murine endometrial cell relative TGFB mRNA expression in the pre-implantation 
period. All Tgfb isoforms were consistently more highly expressed in the stromal 
compartment post mating. With the exception of Tgfb1 which demonstrated a reduction in 
stromal compartment expression, all isoforms exhibited a rise in expression in day 1 post 
mating. 
 
Figure VI: Relative Ifnb and Ifng expression in murine endometrial cell compartments post 
mating. Ifnb exhibited a sharp peak in expression on day 2 post mating in the stromal 
compartment, while Ifng showed a peak at this time point in the epithelium. 
 
Figure VII: Relative expression (mean normalised intensity) of Lif, Tnf and Ccl5 in murine 
endometrial epithelial and stromal compartments. Lif expression remained relatively constant 
excepting at Day 4, while Tnf expression profiles were similar in both compartments 
although with higher expression in the stromal compartment at all days except Day 4. Ccl5 
expression was consistently more highly expressed in the stromal compartment. 
 
Figure VIII: Murine endometrial expression of prostaglandin pathway elements during the 
pre-implantation period. Synthases Ptgs1 and Ptgs2 peaked on day 2 in the epithelium with 
a subsequent decline to day 4. Receptor expression varied, with Ptger1 and Ptger3 having 
relatively higher stromal expression while Ptger2 and Ptger4 followed the opposite pattern. 
 
Supplementary Figure I: Example of laser capture microdissection of murine endometrial 
epithelial and stromal compartments. Epithelial and stromal compartments were identified 
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and excised. Areas pre- and post-excision are highlighted in green (top panel epithelial 
compartment, bottom panel stromal compartment).  
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Table I: Pathways active in murine endometrial epithelial and stromal cells. 1 







GPCRs, Class A Rhodopsin-like  WP189 62834 0.00 208 231 
GPCRs, Other  WP41 54691 0.00 150 210 
GPCRs, Other  WP41 62667 0.00 150 210 
Cytoplasmic Ribosomal Proteins  WP163 62833 0.00 77 80 
Peptide GPCRs  WP234 41308 0.00 63 70 
Metapathway biotransformation  WP1251 41349 0.00 117 143 
Monoamine GPCRs  WP570 48232 0.00 32 33 
Monoamine GPCRs  WP570 60231 0.00 32 33 
Calcium Regulation in the Cardiac Cell  WP553 47774 0.00 120 150 
Striated Muscle Contraction WP216 41273 0.00 40 45 
Complement and Coagulation Cascades  WP449 41301 0.00 53 62 
Prostaglandin Synthesis and Regulation  WP374 41394 0.00 29 31 
Small Ligand GPCRs  WP353 41279 0.00 18 18 
Selenium  WP1272 58514 0.00 22 31 
Cytokines and Inflammatory Response 
(BioCarta)  WP222 53571 0.00 26 30 
Selenium  WP1272 59028 0.00 21 31 
Complement Activation, Classical Pathway  WP200 47967 0.00 16 17 
Cytochrome P450  WP1274 48227 0.00 35 40 
Myometrial Relaxation and Contraction 
Pathways WP385 47969 0.00 120 157 
Blood Clotting Cascade  WP460 62696 0.00 19 20 
Glucocorticoid & Mineralcorticoid 
Metabolism  WP495 62838 0.00 13 13 
SIDS Susceptibility Pathways  WP1266 58254 0.00 49 61 
SIDS Susceptibility Pathways  WP1266_58281 0.00 49 61 
GPCRs, Class B Secretin-like  WP456 41317 0.01 20 22 
Nuclear receptors in lipid metabolism and 
toxicity  WP431 47744 0.01 26 30 
Glucuronidation  WP1241 59029 0.01 11 18 
Irinotecan Pathway  WP475 48258 0.01 11 11 
Matrix Metalloproteinases  WP441 41300 0.01 25 29 
Macrophage markers  WP2271 53132 0.01 10 10 
XPodNet - protein-protein interactions in the 
podocyte expanded by STRING  WP2309 58142 0.01 573 836 
XPodNet - protein-protein interactions in the 
podocyte expanded by STRING  WP2309 58143 0.01 573 836 
Oxidative Stress  WP412 41381 0.02 24 29 
GPCRs, Class C Metabotropic glutamate, 
pheromone  WP327 41361 0.02 14 15 
Folic Acid Network  WP1273 48256 0.02 20 27 
Inflammatory Response Pathway  WP458 57463 0.03 25 30 
TGFβ Signaling Pathway  WP113 41270 0.03 41 52 
Metapathway biotransformation  WP1251 59060 0.03 22 143 
Hedgehog Signaling Pathway  WP116 41332 0.03 19 22 
Folic Acid Network  WP1273 60224 0.03 19 27 
Glycolysis and Gluconeogenesis  WP157 43573 0.03 38 48 
Endochondral Ossification  WP1270 41292 0.03 48 62 
Serotonin and anxiety-related events  WP2140 58159 0.03 12 13 
Glycolysis and Gluconeogenesis  WP157 51735 0.04 39 50 
ESC Pluripotency Pathways  WP339 42897 0.04 81 111 
Retinol metabolism  WP1259 51364 0.04 31 39 
Oestrogen metabolism  WP1264 48250 0.04 11 13 
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